{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Plainsboro",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "98100",
      "recalling_firm": "Novo Nordisk Inc.",
      "address_1": "800 Scudders Mill Rd",
      "address_2": "N/A",
      "postal_code": "08536-1606",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States.",
      "recall_number": "D-0244-2026",
      "product_description": "Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14",
      "product_quantity": "N/A",
      "reason_for_recall": "Presence of Particulate Matter: Hair was found in a prefilled syringe",
      "recall_initiation_date": "20251219",
      "center_classification_date": "20251231",
      "report_date": "20260107",
      "code_info": "Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026"
    }
  ]
}